Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Aspirin may cut risk of breast cancer

  • Comment

A daily dose of aspirin may lower a woman’s risk of developing a common type of breast cancer, claim US researchers.

Around three-quarters of breast cancers are oestrogen receptor-positive, and the researchers found that women who took a daily aspirin were 16% less likely to develop these types of breast cancers.

They studied the use of aspirin - and other nonsteroidal anti-inflammatory drugs (NSAIDs) – in over 126,000 women, aged between 51 and 72.

At the start of the study, none of the women had breast cancer. During follow-up, 4,501 of the women developed the disease.

The authors said that although breast cancer risk was not significantly associated with NSAID use, daily aspirin was associated with a modest reduction in oestrogen receptor-positive breast cancers.

But Liz Baker, science information officer at Cancer Research UK, warned: ‘It's important to remember that taking aspirin for a long time can have harmful side-effects, including heart problems and stomach ulcers.

‘Weighing up the risks and benefits, it’s too soon to recommend aspirin as a way of reducing the risk of cancer. Cancer ResearchUKwould urge people to speak to their doctor before taking aspirin regularly.’

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs